AT1s profits are in the wholesale of the testing device, how successful the companies who buy them are at making an effective test does not eat in to AT1s profits. They order them, pay then the rest is on them. 1 company has ordered more than they can currently supply and they are ramping up production (initially to expand HIV test kits, which will still stand post COVID). 3 other companies have made enquiries and if there is scope to produce more they may purchase them as well. This puts their name out there and show cases their product and it will continue to grow in other applications once COVID is over. Hopefully.
AT1s profits are in the wholesale of the testing device, how...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.42M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87119 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 5000 | 1 |
View Market Depth
| Last trade - 09.59am 22/08/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable